TNDM 250117 35.00P (TNDM250117P35000) Stock Options, News & Quotes

US OptionsDetailed Quotes

TNDM250117P35000

Watchlist

0.25
+0.20+400.00%

15min DelayClose Jan 17 16:00 ET

0.50High0.10Low

Intraday

5D
Daily

News

Press Release: Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
Dow JonesJan 15 16:06 ET
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
Tandem Diabetes Care Jan 15 00:00 ET
Bernstein Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Raises Target Price to $44
Moomoo NewsJan 8 07:34 ET · Ratings
Tandem Diabetes Care (NASDAQ:TNDM) Shareholders Have Endured a 71% Loss From Investing in the Stock Three Years Ago
Simply Wall StJan 8 05:42 ET
RBC Capital Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $65
Moomoo NewsJan 7 21:32 ET · Ratings
Diabetes Device Maker Beta Bionics Files for $100M IPO
Seeking AlphaJan 7 16:44 ET

Comments

mad541

Aug 2, 2024 11:48

company needs money this always drops 35% after earnings I'm out

mad541

Aug 2, 2024 11:46

$Tandem Diabetes Care (TNDM.US)$ company needs money this always drops 35% after earnings I'm out 🩸🩸🩸

Trytosaveabit

Aug 1, 2024 15:13

Update

$Tandem Diabetes Care (TNDM.US)$ Second Quarter 2024 Highlights
-- Worldwide GAAP sales increased 13 percent to $221.9 million compared to
second quarter 2023; worldwide non-GAAP sales(1) increased 12 percent to
$221.8 million compared to second quarter 2023.
-- More than 20,000 pumps shipped in the United States, a sequential
increase of 33 percent compared to first quarter 2024.
-- Launched Tandem Mobi with Dexcom G7 continuous glucose monitoring (CGM)
sensor integration in th...

70862468

May 21, 2024 11:11

Stock moves

$Tandem Diabetes Care (TNDM.US)$
Just check call options. they are expensive
However, stock price moves only 5-10% with no news. Something is going on behind the scene?!

Moomoo AI

Mar 22, 2024 05:56

Despite losses and negative cash flow, the company's US$178.2m balance sheet allows for at least two years of growth spending. However, the stock is seen as risky due to these financial conditions.

Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?